These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 32474864)

  • 1. Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter.
    Butterfield KT; McGrath PS; Han CM; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2155():11-21. PubMed ID: 32474864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives.
    Oceguera-Yanez F; Kim SI; Matsumoto T; Tan GW; Xiang L; Hatani T; Kondo T; Ikeya M; Yoshida Y; Inoue H; Woltjen K
    Methods; 2016 May; 101():43-55. PubMed ID: 26707206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
    Thamodaran V; Rani S; Velayudhan SR
    Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.
    Hong SG; Yada RC; Choi K; Carpentier A; Liang TJ; Merling RK; Sweeney CL; Malech HL; Jung M; Corat MAF; AlJanahi AA; Lin Y; Liu H; Tunc I; Wang X; Palisoc M; Pittaluga S; Boehm M; Winkler T; Zou J; Dunbar CE
    Mol Ther; 2017 Jan; 25(1):44-53. PubMed ID: 28129126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Transgene Silencing of Myeloid-Specific Promoters in the
    Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
    Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
    Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas-Mediated Knock-in of Genetically Encoded Fluorescent Biosensors into the AAVS1 Locus of Human-Induced Pluripotent Stem Cells.
    Stellon D; Tran MTN; Talbot J; Chear S; Khalid MKNM; Pébay A; Vickers JC; King AE; Hewitt AW; Cook AL
    Methods Mol Biol; 2022; 2549():379-398. PubMed ID: 34505269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.
    Wen W; Cheng X; Fu Y; Meng F; Zhang JP; Zhang L; Li XL; Yang Z; Xu J; Zhang F; Botimer GD; Yuan W; Sun C; Cheng T; Zhang XB
    Stem Cell Reports; 2018 Jun; 10(6):1821-1834. PubMed ID: 29754960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent labeling and visualization of human induced pluripotent stem cells with the use of transcription activator-like effector nucleases.
    Sekine K; Takebe T; Taniguchi H
    Transplant Proc; 2014 May; 46(4):1205-7. PubMed ID: 24815161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases.
    Luo Y; Liu C; Cerbini T; San H; Lin Y; Chen G; Rao MS; Zou J
    Stem Cells Transl Med; 2014 Jul; 3(7):821-35. PubMed ID: 24833591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Doxycycline-Inducible System for Genetic Correction of iPSC Disease Models.
    Sim X; Cardenas-Diaz FL; French DL; Gadue P
    Methods Mol Biol; 2016; 1353():13-23. PubMed ID: 25630922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 nuclease-mediated gene knock-in in bovine-induced pluripotent cells.
    Heo YT; Quan X; Xu YN; Baek S; Choi H; Kim NH; Kim J
    Stem Cells Dev; 2015 Feb; 24(3):393-402. PubMed ID: 25209165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease.
    Lee Y; Choi HY; Kwon A; Park H; Park M; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Oct; 40():101554. PubMed ID: 31499408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.